Aryeh Jason

Track

Insider profile

Performance

Overall performance
2.4
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -14% 8.2% 15.1%
Success rate 3% 68% 82%
Transactions
13 62% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 143%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Aryeh Jason's trades of Ligand Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
125.64
Quantity 9,219 -3.3%
Value US$1,996,169
Transaction date
Sale
Price
241.22
Quantity 2,097 +22.7%
Value US$3,722,498
Transaction date
Proposed sale
Price
170.81
Quantity 10,000
Value US$1,708,087
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-12 2026-06-11
S Sale
9,219 -3.3%
125.64
US$1,996,169 		9,219 -3.3% 125.64 US$1,996,169
2026-06-11 2026-06-11
PrS Proposed sale
97,696
321.26
US$3,542,541 		97,696 321.26 US$3,542,541
2026-06-12 2026-06-10
S Sale
2,097 +22.7%
241.22
US$3,722,498 		2,097 +22.7% 241.22 US$3,722,498
2026-06-10 2026-06-10
PrS Proposed sale
500
249.96
US$124,980 		500 249.96 US$124,980
2026-06-10 2026-06-10
PrS Proposed sale
5,000
249.35
US$1,246,750 		5,000 249.35 US$1,246,750
2026-05-20 2026-05-18
B Purchase
665 +0.6%
3.75
US$2,494 		665 +0.6% 3.75 US$2,494
2026-05-19 2026-05-15
B Purchase
8,971 +8.3%
3.90
US$34,987 		8,971 +8.3% 3.90 US$34,987
2025-09-24 2025-09-23
S Sale
954 -1.4%
171.92
US$164,015 		954 -1.4% 171.92 US$164,015
2025-09-24 2025-09-23
S Sale
4,628 -6.2%
170.96
US$791,223 		4,628 -6.2% 170.96 US$791,223
2025-09-24 2025-09-23
S Sale
4,418 -5.6%
170.41
US$752,850 		4,418 -5.6% 170.41 US$752,850
2025-09-23 2025-09-23
PrS Proposed sale
10,000
170.81
US$1,708,087 		10,000 170.81 US$1,708,087
2025-09-19 2025-09-19
B Purchase
1,000 +0.9%
2.45
US$2,450 		1,000 +0.9% 2.45 US$2,450
2025-09-17 2025-09-17
PrS Proposed sale
10,000
168.50
US$1,685,000 		10,000 168.50 US$1,685,000
2019-09-04 2019-09-03
PP Planned purchase
750 +1.1%
87.01
US$65,258 		750 +1.1% 87.01 US$65,258
2019-07-31 2019-07-31
PP Planned purchase
754 +1.2%
93.00
US$70,122 		754 +1.2% 93.00 US$70,122
2019-07-31 2019-07-30
PP Planned purchase
3,000 +4.8%
100.22
US$300,663 		3,000 +4.8% 100.22 US$300,663
2019-07-31 2019-07-29
PP Planned purchase
250 +0.4%
106.01
US$26,502 		250 +0.4% 106.01 US$26,502
2019-07-18 2019-07-16
B Purchase
302 +8.6%
5.44
US$1,643 		302 +8.6% 5.44 US$1,643
2019-07-15 2019-07-12
B Purchase
1,000 +40.0%
5.62
US$5,620 		1,000 +40.0% 5.62 US$5,620
2019-07-15 2019-07-12
B Purchase
2,400 +2400.0%
5.71
US$13,704 		2,400 +2400.0% 5.71 US$13,704
2019-07-15 2019-07-11
B Purchase
100 +inf%
5.71
US$571 		100 +inf% 5.71 US$571
2019-06-12 2019-06-11
PP Planned purchase
250 +0.4%
107.01
US$26,752 		250 +0.4% 107.01 US$26,752
2019-05-31 2019-05-31
PP Planned purchase
500 +0.8%
108.51
US$54,255 		500 +0.8% 108.51 US$54,255
2019-05-31 2019-05-30
PP Planned purchase
250 +0.4%
110.01
US$27,502 		250 +0.4% 110.01 US$27,502
2019-05-31 2019-05-29
PP Planned purchase
250 +0.4%
111.01
US$27,752 		250 +0.4% 111.01 US$27,752
2019-05-22 2019-05-20
PP Planned purchase
250 +0.4%
112.01
US$28,002 		250 +0.4% 112.01 US$28,002
2019-05-16 2019-05-14
PP Planned purchase
250 +0.4%
112.51
US$28,128 		250 +0.4% 112.51 US$28,128
2019-03-15 2019-03-13
B Purchase
202 +0.4%
112.51
US$22,727 		202 +0.4% 112.51 US$22,727